文献速递气道管理术前评估与围术期医学

术中经鼻高流量氧疗有效性的系统评价与荟萃分析

The Effectiveness of High-Flow Nasal Oxygen During the Intraoperative Period: A Systematic Review and Meta-analysis.
PubMed 文献 · Anesth Analg · 2020-01-01

该系统评价与荟萃分析纳入8项随机对照试验(共2314例患者),比较术中经鼻高流量氧疗(HFNO)与常规氧疗对氧合及呼气末二氧化碳(EtCO2)的影响。结果显示,HFNO降低术中氧去饱和风险、提高最低氧饱和度并延长安全呼吸暂停时间,且诱导期EtCO2无显著差异。建议对低氧血症高风险患者在麻醉诱导及无气管插管的镇静手术中考虑使用HFNO。

要点

  • HFNO降低术中氧去饱和风险,诱导期OR 0.06,手术期OR 0.09。
  • HFNO提高最低氧饱和度,诱导期MD 5.1%,手术期MD 4.0%。
  • HFNO延长诱导期安全呼吸暂停时间33.4秒,EtCO2无显著差异。

核心结论

  • 术中HFNO较常规氧疗降低氧去饱和风险、提高最低氧饱和度并延长安全呼吸暂停时间。
  • 对低氧血症高风险患者,麻醉诱导及无气管插管的镇静手术中应考虑使用HFNO。

研究设计与样本

  • 系统评价与荟萃分析,检索标准数据库至2020年2月。
  • 纳入8项随机对照试验(RCT),共2314例患者,其中4项为诱导期,4项为手术期。

主要发现

  • 诱导期EtCO2在HFNO与常规氧疗组间无显著差异。

临床怎么用

  • 对低氧血症高风险患者,麻醉诱导时可考虑使用HFNO以降低氧去饱和风险。
  • 无气管插管的镇静手术中可考虑使用HFNO以维持氧合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High-flow nasal oxygen (HFNO) is increasingly being used in intensive care units for management of hypoxemia and respiratory failure. However, the effectiveness of HFNO for preventing hypoxemia in the intraoperative period is unclear. The purpose of this systematic review was to compare patient oxygenation and end-tidal CO2 (EtCO2), between HFNO and conventional oxygenation, during the intraoperative period in surgical patients. METHODS: Standard databases were searched from inception to February 2020. Studies involving intraoperative use of HFNO with 1 of the 4 outcomes: (1) oxygen (O2) desaturation, (2) minimum O2 saturation, (3) safe apnea time, or (4) EtCO2 were included. Intraoperative period was divided into 2 phases: at induction with general anesthesia and during surgical procedure under sedation without tracheal intubation. RESULTS: Eight randomized controlled trials (RCTs; 4 induction, 4 procedure, 2314 patients) were included for systematic review and meta-analyses. We found the risk of intraoperative O2 desaturation was lower in HFNO versus conventional oxygenation control group; at induction with an odds ratio (OR; 95% confidence interval [CI]) of 0.06 (0.01-0.59, P = .02), and during procedure, OR (95% CI) of 0.09 (0.05-0.18; P < .001). The minimum O2 saturation was higher in HFNO versus conventional oxygenation; at induction by a mean difference (MD) (95% CI) of 5.1% (3.3-6.9; P < .001), and during procedure, by a MD (95% CI) of 4.0% (1.8-6.2; P < .001). Safe apnea time at induction was longer in HFNO versus conventional oxygenation by a MD (95% CI) of 33.4 seconds (16.8-50.1; P < .001). EtCO2 at induction was not significantly different between HFNO and conventional oxygenation groups. CONCLUSIONS: This systematic review and meta-analysis show that, in the intraoperative setting, HFNO compared to conventional oxygenation reduces the risk of O2 desaturation, increases minimum O2 saturation, and safe apnea time. HFNO should be considered for anesthesia induction and during surgical procedures under sedation without tracheal intubation in patients at higher risk of hypoxemia.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Spence EA, Rajaleelan W, Wong J, et al. The Effectiveness of High-Flow Nasal Oxygen During the Intraoperative Period: A Systematic Review and Meta-analysis. Anesth Analg. 2020. PMID: 32925331. doi:10.1213/ANE.0000000000005073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。